JOYZYME GROUP (08622) announced its interim results, reporting a loss of 2.428 million yuan, an increase of 2.49% year-on-year.

01:25 29/08/2026

Yuyue Group (08622) announced its results for the six months ending June 30, 2026. During this period, the Group achieved a revenue of 16.557 million yuan, an increase of 34.29% year-on-year; the loss for the period was 2.428 million yuan, widening by 2.49% compared to the previous year; the basic loss per share was 0.47 cents.

JOYZYME GROUP (08622) announced its performance for the six months ended June 30, 2026, during which the group achieved a revenue of RMB 16.557 million, an increase of 34.29% year-on-year; the loss during the period was RMB 2.428 million, an increase of 2.49% year-on-year; basic loss per share was 0.47 cents.

After Cursor was acquired by SpaceX (SPCX.US), OpenAI announced the termination of cooperation citing Musk's "breach of contract history."

Electra Therapeutics (ETRA.US) has submitted an IPO application for the U.S. stock market, leveraging the current biotech IPO boom to advance the development of new drugs for immune diseases and cancer.

Blue Owl (OWL.US) has teamed up with PIMCO to customize a $2.4 billion GPU financing for IREN (IREN.US).

After Cursor was acquired by SpaceX (SPCX.US), OpenAI announced the termination of cooperation citing Musk's "breach of contract history."

Blue Owl (OWL.US) has teamed up with PIMCO to customize a $2.4 billion GPU financing for IREN (IREN.US).